Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome

Sreenivasarao Vepachedu

Case Conclusion Date:April 19, 2011

Practice Area:Patent Application

Outcome:Grant

Description:The present invention relates to compounds, pharmaceutical compositions, and related methods for the treatment or prevention of various diseases such as diabetes, obesity, and metabolic syndrome.